These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 19222228)
1. Use of divalent metal ions in the dna cleavage reaction of human type II topoisomerases. Deweese JE; Burch AM; Burgin AB; Osheroff N Biochemistry; 2009 Mar; 48(9):1862-9. PubMed ID: 19222228 [TBL] [Abstract][Full Text] [Related]
2. Metal ion interactions in the DNA cleavage/ligation active site of human topoisomerase IIalpha. Deweese JE; Guengerich FP; Burgin AB; Osheroff N Biochemistry; 2009 Sep; 48(38):8940-7. PubMed ID: 19697956 [TBL] [Abstract][Full Text] [Related]
3. Human topoisomerase IIalpha uses a two-metal-ion mechanism for DNA cleavage. Deweese JE; Burgin AB; Osheroff N Nucleic Acids Res; 2008 Sep; 36(15):4883-93. PubMed ID: 18653531 [TBL] [Abstract][Full Text] [Related]
4. Use of divalent metal ions in the DNA cleavage reaction of topoisomerase IV. Pitts SL; Liou GF; Mitchenall LA; Burgin AB; Maxwell A; Neuman KC; Osheroff N Nucleic Acids Res; 2011 Jun; 39(11):4808-17. PubMed ID: 21300644 [TBL] [Abstract][Full Text] [Related]
5. The impact of the C-terminal domain on the interaction of human DNA topoisomerase II α and β with DNA. Gilroy KL; Austin CA PLoS One; 2011 Feb; 6(2):e14693. PubMed ID: 21358820 [TBL] [Abstract][Full Text] [Related]
6. Overcoming target-mediated quinolone resistance in topoisomerase IV by introducing metal-ion-independent drug-enzyme interactions. Aldred KJ; Schwanz HA; Li G; McPherson SA; Turnbough CL; Kerns RJ; Osheroff N ACS Chem Biol; 2013 Dec; 8(12):2660-8. PubMed ID: 24047414 [TBL] [Abstract][Full Text] [Related]
7. The use of divalent metal ions by type II topoisomerases. Deweese JE; Osheroff N Metallomics; 2010 Jul; 2(7):450-9. PubMed ID: 20703329 [TBL] [Abstract][Full Text] [Related]
8. Using 3'-bridging phosphorothiolates to isolate the forward DNA cleavage reaction of human topoisomerase IIalpha. Deweese JE; Burgin AB; Osheroff N Biochemistry; 2008 Apr; 47(13):4129-40. PubMed ID: 18318502 [TBL] [Abstract][Full Text] [Related]
9. Mutation of cysteine residue 455 to alanine in human topoisomerase IIalpha confers hypersensitivity to quinones: enhancing DNA scission by closing the N-terminal protein gate. Bender RP; Osheroff N Chem Res Toxicol; 2007 Jun; 20(6):975-81. PubMed ID: 17516663 [TBL] [Abstract][Full Text] [Related]
10. Bimodal recognition of DNA geometry by human topoisomerase II alpha: preferential relaxation of positively supercoiled DNA requires elements in the C-terminal domain. McClendon AK; Gentry AC; Dickey JS; Brinch M; Bendsen S; Andersen AH; Osheroff N Biochemistry; 2008 Dec; 47(50):13169-78. PubMed ID: 19053267 [TBL] [Abstract][Full Text] [Related]
11. Catalytic core of human topoisomerase IIα: insights into enzyme-DNA interactions and drug mechanism. Lindsey RH; Pendleton M; Ashley RE; Mercer SL; Deweese JE; Osheroff N Biochemistry; 2014 Oct; 53(41):6595-602. PubMed ID: 25280269 [TBL] [Abstract][Full Text] [Related]
12. Mutation P732L in human DNA topoisomerase IIbeta abolishes DNA cleavage in the presence of calcium and confers drug resistance. Leontiou C; Lakey JH; Lightowlers R; Turnbull RM; Austin CA Mol Pharmacol; 2006 Jan; 69(1):130-9. PubMed ID: 16239602 [TBL] [Abstract][Full Text] [Related]
13. Biochemical characterization of human tyrosyl-DNA phosphodiesterase 2 (TDP2/TTRAP): a Mg(2+)/Mn(2+)-dependent phosphodiesterase specific for the repair of topoisomerase cleavage complexes. Gao R; Huang SY; Marchand C; Pommier Y J Biol Chem; 2012 Aug; 287(36):30842-52. PubMed ID: 22822062 [TBL] [Abstract][Full Text] [Related]
14. Coordinating the two protomer active sites of human topoisomerase IIalpha: nicks as topoisomerase II poisons. Deweese JE; Osheroff N Biochemistry; 2009 Feb; 48(7):1439-41. PubMed ID: 19166355 [TBL] [Abstract][Full Text] [Related]
15. Impact of the C-terminal domain of topoisomerase IIalpha on the DNA cleavage activity of the human enzyme. Dickey JS; Osheroff N Biochemistry; 2005 Aug; 44(34):11546-54. PubMed ID: 16114891 [TBL] [Abstract][Full Text] [Related]
16. The geometry of DNA supercoils modulates topoisomerase-mediated DNA cleavage and enzyme response to anticancer drugs. McClendon AK; Osheroff N Biochemistry; 2006 Mar; 45(9):3040-50. PubMed ID: 16503659 [TBL] [Abstract][Full Text] [Related]
17. DNA cleavage and opening reactions of human topoisomerase IIα are regulated via Mg2+-mediated dynamic bending of gate-DNA. Lee S; Jung SR; Heo K; Byl JA; Deweese JE; Osheroff N; Hohng S Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2925-30. PubMed ID: 22323612 [TBL] [Abstract][Full Text] [Related]
18. Human topoisomerase IIalpha possesses an intrinsic nucleic acid specificity for DNA ligation. Use of 5' covalently activated oligonucleotide substrates to study enzyme mechanism. Bromberg KD; Hendricks C; Burgin AB; Osheroff N J Biol Chem; 2002 Aug; 277(34):31201-6. PubMed ID: 12050172 [TBL] [Abstract][Full Text] [Related]
19. Cobalt enhances DNA cleavage mediated by human topoisomerase II alpha in vitro and in cultured cells. Baldwin EL; Byl JA; Osheroff N Biochemistry; 2004 Jan; 43(3):728-35. PubMed ID: 14730977 [TBL] [Abstract][Full Text] [Related]
20. Exocyclic DNA lesions stimulate DNA cleavage mediated by human topoisomerase II alpha in vitro and in cultured cells. Vélez-Cruz R; Riggins JN; Daniels JS; Cai H; Guengerich FP; Marnett LJ; Osheroff N Biochemistry; 2005 Mar; 44(10):3972-81. PubMed ID: 15751973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]